{"id":2964,"date":"2024-10-11T06:44:13","date_gmt":"2024-10-11T06:44:13","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/the-supplement-explanatory-document-to-vich-gl52\/"},"modified":"2024-10-24T09:03:53","modified_gmt":"2024-10-24T09:03:53","slug":"the-supplement-explanatory-document-to-vich-gl52","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/es\/guidline\/the-supplement-explanatory-document-to-vich-gl52\/","title":{"rendered":"El documento explicativo complementario al VICH GL52VICH GL52"},"content":{"rendered":"<p>VICH GL52<\/p>\n","protected":false},"menu_order":51,"template":"","meta":[],"guideline_category":[231],"class_list":["post-2964","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-efficacy-bioequivalence-es"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline\/2964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/media?parent=2964"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline_category?post=2964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}